Novartis decides not to make offer to acquire Berna Biotech
12-Jan-2006
After completion of due diligence and an assessment of the potential benefits and risks of an acquisition, Novartis has decided not to make an offer for Berna Biotech AG.
Novartis announced in December that it was considering whether to acquire Berna Biotech AG after Crucell N.V. made an offer earlier in December to acquire the Swiss company through an all-share exchange offer.
Organizations
Berna Biotech
Novartis
Crucell
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.